Jana Šímová
-
Serum Levels of Matrix Metalloproteinases 2 and 9 in Patients with Acute Myocardial Infarction
Jana Šímová, J. Škvor, D. Slovák, I. Mazura, J. Zvárová
2013, Vol. 59, Issue 5, pp. 181-187 -
Serum Levels of Matrix Metalloproteinases 2 and 9 and TGFBR2 Gene Screening in Patients with Ascending Aortic Dilatation
Jana Šímová, J. Škvor, J. Reissigová, J. Dudra, J. Lindner, P. Čapek, J. Zvárová
2013, Vol. 59, Issue 4, pp. 154-161 -
Immunotherapeutic Efficacy of Vaccines Generated by Fusion of Dendritic Cells and HPV16-Associated Tumour Cells
Jana Šímová, J. Bubeník, J. Bieblová, M. Indrová, T. Jandlová
2005, Vol. 51, Issue 1, pp. 19-24 -
The Role of NK1.1+ Cells in the Protection against MHC Class I+ HPV16-Associated Tumours
Jana Šímová, J. Bubeník, J. Bieblová, T. Jandlová
2004, Vol. 50, Issue 6, pp. 200-202 -
MHC Class I+ and Class I- HPV16-Associated Tumours Expressing the E7 Oncoprotein Do Not Cross-react in Immunization/Challenge Experiments
Jana Šímová, R. Mikyšková, V. Vonka, J. Bieblová, J. Bubeník, T. Jandlová
2003, Vol. 49, Issue 6, pp. 230-234 -
Immunotherapy of HPV 16-Associated Tumours with Tumour Cell Line/Dendritic Cell Line (TC-1/DC2.4) Hybrid Vaccines
Jana Šímová, J. Bieblová, T. Jandlová, J. Bubeník
2003, Vol. 49, Issue 5, pp. 203-206
